Cargando…

CKD Progression and Economic Burden in Individuals With CKD Associated With Type 2 Diabetes

RATIONALE & OBJECTIVE: To evaluate progression patterns and associated economic outcomes, using estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (UACR) based on the Kidney Disease: Improving Global Outcomes (KDIGO) risk categories, among patients with type 2 diabete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mullins, C. Daniel, Pantalone, Kevin M., Betts, Keith A., Song, Jinlin, Wu, Aozhou, Chen, Yan, Kong, Sheldon X., Singh, Rakesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630787/ https://www.ncbi.nlm.nih.gov/pubmed/36339666 http://dx.doi.org/10.1016/j.xkme.2022.100532

Ejemplares similares

CKD Prevalence Among Patients With and Without Type 2 Diabetes: Regional Differences in the United States
por: Feng, Xue (Snow), et al.
Publicado: (2021)

Risk Factors for Progression of CKD with and without Diabetes
por: Zhang, Xiaohong, et al.
Publicado: (2022)

CKD: The burden of disease invisible to research funders
Publicado: (2022)

CKD: The burden of disease invisible to research funders
Publicado: (2022)

The Burden of Mental Health Conditions in Children With CKD
por: Kurzinski, Katherine L., et al.
Publicado: (2022)

Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts
por: Canney, Mark, et al.
Publicado: (2023)

Diabetic Nephropathy and CKD—Analysis of Individual Patient Serum Creatinine Trajectories: A Forgotten Diagnostic Methodology for Diabetic CKD Prognostication and Prediction
por: Onuigbo, Macaulay Amechi Chukwukadibia, et al.
Publicado: (2015)

Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism
por: Uchiyama-Matsuoka, Natsumi, et al.
Publicado: (2022)

Progression of Medial Arterial Calcification in CKD
por: Manzoor, Shumila, et al.
Publicado: (2018)

A predictive model for progression of CKD
por: Chang, Hsueh-Lu, et al.
Publicado: (2019)

Optimizing Diet to Slow CKD Progression
por: Molina, Pablo, et al.
Publicado: (2021)

Plasma Biomarkers and Incident CKD Among Individuals Without Diabetes
por: Le, Dustin, et al.
Publicado: (2023)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

Constipation in CKD
por: Sumida, Keiichi, et al.
Publicado: (2019)

Urinary Metabolite Profile Predicting the Progression of CKD
por: Kim, Yaerim, et al.
Publicado: (2023)

Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes
por: Cabrera, Claudia S., et al.
Publicado: (2020)

CKD Awareness in the General Population: Performance of CKD-Specific Questions
por: Tuot, Delphine S., et al.
Publicado: (2019)

Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD
por: Norris, Keith C., et al.
Publicado: (2019)

Soluble ST2 and Galectin-3 and Progression of CKD
por: Alam, Mariam L., et al.
Publicado: (2018)

Chapter 3: Management of progression and complications of CKD
Publicado: (2013)

Self-reported Medication Adherence and CKD Progression
por: Cedillo-Couvert, Esteban A., et al.
Publicado: (2018)

APOL1, Acid Load, and CKD Progression
por: Pike, Mindy, et al.
Publicado: (2019)

Risk Factors and Rate of Progression of CKD in Children
por: Kamath, Nivedita, et al.
Publicado: (2019)

Eubicarbonatemic Hydrogen Ion Retention and CKD Progression
por: Madias, Nicolaos E.
Publicado: (2021)

CKD Prevalence in the Military Health System: Coded Versus Uncoded CKD
por: Norton, Jenna M., et al.
Publicado: (2021)

TG/HDL-C Ratio Is a Risk Factor Associated with CKD: Use in Assessing the Risk of Progression of CKD
por: Nguyen, Ha Hong, et al.
Publicado: (2022)

Stirring the Pot: Can Dietary Modification Alleviate the Burden of CKD?
por: Snelson, Matthew, et al.
Publicado: (2017)

Cardiovascular Risk Factor Burden and Association With CKD in Ghana and Nigeria
por: Olanrewaju, Timothy O., et al.
Publicado: (2022)

Hospitalization Trajectories and Risks of ESKD and Death in Individuals With CKD
por: Srivastava, Anand, et al.
Publicado: (2021)

Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKD
por: Zhang, Hui, et al.
Publicado: (2019)

Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013)

CKD in disadvantaged populations
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2015)

Editorial: Biomarkers in CKD
por: Araujo, Magali, et al.
Publicado: (2017)

Frailty in CKD and Transplantation
por: Lorenz, Elizabeth C., et al.
Publicado: (2021)

Phosphate, Microbiota and CKD
por: Favero, Chiara, et al.
Publicado: (2021)

The Role of Inflammation in CKD
por: Kadatane, Saurav Prashant, et al.
Publicado: (2023)

Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled study
por: Chase, Herbert S, et al.
Publicado: (2014)

CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis
por: Argilés, Àngel, et al.
Publicado: (2013)

Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology
por: Venuthurupalli, Sree K., et al.
Publicado: (2018)

Prevalence of CKD, Diabetes, and Hypertension in Rural Tanzania
por: Ploth, David W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4u0g46cko8da98oaopkssnb74g